OS Therapies IncorporatedOSTXNYSE
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank25
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-10.06
↑ 99% vs avg
Percentile
P25
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
-708.20
Historical baseline
PeriodValueYoY Change
2024-10.06-55.7%
2023-6.46+30.3%
2022-9.27-18.6%
2021-7.81+99.8%
2020-3507.42-